Jean-Christophe Renondin
Directeur/Bestuurslid bij ABL DIAGNOSTICS
Vermogen: - $ op 30-04-2024
Oorsprong van het eerstegraads netwerk van Jean-Christophe Renondin
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 13 | |
Cognate BioServices, Inc.
 Cognate BioServices, Inc. BiotechnologyHealth Technology Cognate BioServices, Inc. engages in the provision of commercialization services to regenerative medicine, cellular immunotherapy, and cell therapy companies. It offers cGMP clinical and commercial manufacturing; process and assay development and optimization; logistics, supply chain, and manufacturing support services; and clinical, regulatory, and custom services. The company was founded in 2002 and is headquartered in Memphis, TN.
9
| Subsidiary | Biotechnology | 9 |
Advanced Biological Laboratories SA
 Advanced Biological Laboratories SA Packaged SoftwareTechnology Services Advanced Biological Laboratories SA develops information technology and health solutions for patient management and sequencing data analysis. Its products. Its products are marketed under the brands of TherapyEdge®, ViroScore®, SeqHepB, DeepChek®, VisibleChek®, and HepatiC™. The company was founded by Chalom Bruno Sayada in 2000 and is headquartered in Luxembourg.
8
| Holding Company | Packaged Software | 8 |
Juvenescence Ltd.
 Juvenescence Ltd. Financial ConglomeratesFinance Juvenescence Ltd. engages in operation as an investment holding company which develops therapeutic products for human ageing and longevity. It provides drug development, new company creation, academic licensing, and biotech investment. The company was founded by James Mellon, Gregory H. Bailey, Declan Dooganin, Alexander Pickett, and Anthony Chow in October 2016 and is headquartered in Liverpool, the United Kingdom.
7
| Holding Company | Financial Conglomerates | 7 |
| Public Company | Financial Conglomerates | 6 | |
Innovation Capital SASU
 Innovation Capital SASU Investment ManagersFinance Innovation Capital SASU (Innovation Capital) is the international venture capital subsidiary of CDC Capital Investissement SAS, itself a wholly-owned subsidiary of State-owned CDC Caisse des Dépôts et Consignations in France. Established in 1996 as CDC Entreprises Innovation, the firm was formerly known as CDC Innovation SASU. They changed their name to Innovation Capital SASU in 2012. Located in Paris with representative offices in California and in Switzerland, the firm manages venture capital and innovation mutual funds (FCPRs and FCPIs). Their venture capital funds are sponsored by CDC Capital Investissement, and the innovation funds are generally co-invested with the venture capital funds. The firm's mandate includes public interest missions.
3
| Extinct | Investment Managers | 3 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Jean-Christophe Renondin via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
Mediqventures Ltd.
 Mediqventures Ltd. Finance/Rental/LeasingFinance Mediqventures Ltd. provides financing services for life science technologies. The private company is based in Douglas, UK. The British company was founded by Gregory H. Bailey. | Finance/Rental/Leasing | Director/Board Member Founder Director/Board Member Corporate Officer/Principal | |
| VALERIO THERAPEUTICS | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
| PORTAGE BIOTECH INC. | Biotechnology | Founder Founder Chief Executive Officer | |
| University of Copenhagen | College/University | Corporate Officer/Principal Doctorate Degree Graduate Degree | |
| SALVARX GROUP PLC | Biotechnology | Chairman Founder Director of Finance/CFO | |
| MANX FINANCIAL GROUP PLC | Regional Banks | Chairman Director/Board Member Director/Board Member | |
Praxim SA
 Praxim SA Medical SpecialtiesHealth Technology Praxim SA manufactures and sells orthopedic surgical instruments. It specializes in minimal invasive products for knee arthroscopy. The company was founded by Stéphane Lavallée in 1995 and is headquartered in La Tronche, France. | Medical Specialties | Director/Board Member Director/Board Member | |
| BRADDA HEAD LITHIUM LIMITED | Other Metals/Minerals | Director/Board Member Director of Finance/CFO | |
Key Neurosciences SAS
 Key Neurosciences SAS Miscellaneous Commercial ServicesCommercial Services Key Neurosciences SAS provides research and development services. Its services include product and technology development, fund raising, business and commercial development, and project management. The company was founded in December 2010 and is headquartered in Paris, France. | Miscellaneous Commercial Services | Director/Board Member Chairman | |
| Galloway Ltd. | Director/Board Member Director/Board Member | ||
OxThera AB
 OxThera AB Pharmaceuticals: GenericHealth Technology OxThera AB develops pharmaceutical products for treatment of hyperoxaluria. Its intellectual property includes worldwide patents for compositions and treatment of hyperoxaluria with bacteria and enzymes. The firm?s products in pipeline include Oxabact, for the treatment of primary hyperoxaluria and oxazyme for the prevention of oxalate malabsorption and recurring kidney stones in secondary hyperoxaluria. The company was founded in 2005 and is headquartered in Stockholm, Sweden. | Pharmaceuticals: Generic | Director/Board Member Director/Board Member | |
Shellbay Investments Ltd.
 Shellbay Investments Ltd. Financial ConglomeratesFinance Shellbay Investments Ltd. engages in investment industry. The company is headquartered in the United Kingdom. | Financial Conglomerates | Director/Board Member Director/Board Member | |
Mann Bioinvest Ltd.
 Mann Bioinvest Ltd. Financial ConglomeratesFinance Mann Bioinvest Ltd. invests in the life science sector. The company was founded by James Mellon in 2012 and is headquartered in Douglas, the United Kingdom. | Financial Conglomerates | Founder Director/Board Member | |
| ADOCIA | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Summit Therapeutics Ltd.
 Summit Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Summit Therapeutics Ltd. operates as a holding company, which engages in the discovery, development, and commercialization of antibiotic medicines. The company seeks to expand its product candidate portfolio through the development of new mechanism and precision antibiotics. Summit Therapeutics was founded by Stephen Graham Davies and Kay Dame Davies in January 2003 and is headquartered in Abingdon, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member Chief Operating Officer | |
| PLETHORA SOLUTIONS HOLDINGS PLC | Pharmaceuticals: Major | Chairman Director/Board Member | |
| AGRONOMICS LIMITED | Investment Managers | Founder Director of Finance/CFO | |
AM-Pharma BV
 AM-Pharma BV BiotechnologyHealth Technology AM-Pharma BV operates as a biopharmaceutical company. It engages in the development of proprietary recombinant human Alkaline Phosphatase. The firm’s products include Acute Kidney Injury, Inflammatory Bowel Diseases and Hypophosphatasia. The company was founded in 2001 and is headquartered in Bunnik, the Netherlands. | Biotechnology | Director/Board Member Director/Board Member | |
| WEBIS HOLDINGS PLC | Casinos/Gaming | Director/Board Member Chairman | |
Chelsea Avondale Ltd.
 Chelsea Avondale Ltd. Property/Casualty InsuranceFinance Chelsea Avondale Ltd. has developed Skynet, a precision risk technology for property and casualty insurance. The company is based in Hamilton, Bermuda and has subsidiaries in Barbados. Skynet was created by going back to the scientific principles that cause insurance claims. The first implementation of Skynet was completed in Chelsea Avondale's wholly owned Bermudian insurance company, Max Insurance. Chelsea Avondale believes that scientific underwriting is the future of insurance. The company was founded by Gregory H. Bailey and the CEO is Nilesh Mukundrai G. Vasani. | Property/Casualty Insurance | Director/Board Member Founder | |
| KOLON TISSUEGENE, INC. | Medical Specialties | Chief Operating Officer Corporate Officer/Principal | |
| BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD. | Pharmaceuticals: Major | Director/Board Member Founder | |
OMNI Orthopaedics, Inc.
 OMNI Orthopaedics, Inc. Medical SpecialtiesHealth Technology OMNI Orthopaedics, Inc. designs, manufactures, and distributes orthopedic implants. The company was founded by David L. Lasalle, George B. Cipoletti and Edward J. Cheal on December 22, 2008 and is headquartered in Taunton, MA. | Medical Specialties | Director/Board Member Director/Board Member | |
| VOLUNTIS S.A. | Packaged Software | Director/Board Member Director/Board Member | |
Portage Pharma Ltd.
 Portage Pharma Ltd. Pharmaceuticals: MajorHealth Technology Part of Portage Biotech, Inc., Portage Pharma Ltd. develops pharmaceutical products. The There is no available country named vg company was founded by Declan Doogan, Gregory H. Bailey. Bruce H. Littman has been the CEO of the company since 2013. Portage Pharma was acquired by Portage Biotech, Inc. on June 04, 2013 for $34.84 million. | Pharmaceuticals: Major | Founder Founder | |
| CELLECTIS S.A. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
F2G Ltd.
 F2G Ltd. Pharmaceuticals: MajorHealth Technology F2G Ltd. provides novel drugs for the treatment of life-threatening systemic fungal diseases. It primarily focuses on developing an F3 series of anti mould compound, which is an antifungal agent that acts through a mechanism different from marketed drugs. The company was founded in 1998 and is headquartered in Manchester, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member Chairman | |
| H. LUNDBECK A/S | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| GENOWAY | Biotechnology | Director/Board Member Director/Board Member | |
| CONDOR GOLD PLC | Precious Metals | Chairman Director/Board Member | |
| University of Glasgow | College/University | Doctorate Degree Doctorate Degree | |
Rivington Street Holdings Plc
 Rivington Street Holdings Plc Financial ConglomeratesFinance Rivington Street Holdings Plc engages in the investment and financial business. It operates and provides services through its subsidiaries to listed companies and private investors. The company was founded by Thomas John Zacchaeus Winnifrith in April 2000 and is headquartered in Douglas, Isle of Man. | Financial Conglomerates | Chairman Director/Board Member | |
Warren Pharmaceuticals, Inc.
 Warren Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Warren Pharmaceuticals, Inc. develops tissue-protective technologies. The company was founded by Anthony Cerami and Michael Brines on May 17, 2001 and is headquartered in Tarrytown, NY. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| University of Oxford | College/University | Graduate Degree Undergraduate Degree | |
| PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| OKYO PHARMA LIMITED | Biotechnology | Chairman Director of Finance/CFO | |
| University College London | College/University | Undergraduate Degree Doctorate Degree | |
Roche Innovation Center Copenhagen A/S
 Roche Innovation Center Copenhagen A/S Pharmaceuticals: MajorHealth Technology Roche Innovation Center Copenhagen A/S discovers and develops drugs for the treatment of oncology, metabolic diseases, and infectious diseases. The firm manufactures a pipeline of drug candidates that act selectively on disease-related ribonucleic acid to provide patients with novel treatments for both rare and common diseases. It produces pre-clinical and clinical assets for the treatment of a range of diseases including oncology, metabolic diseases, and infectious diseases. The company was founded by Matts Lundwall and Mikael Ørum on January 1, 1998 and is headquartered in Horsholm, Denmark. | Pharmaceuticals: Major | Chairman Director/Board Member | |
| NXERA PHARMA CO., LTD. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Sleepwell Hotels Ltd.
 Sleepwell Hotels Ltd. Hotels/Resorts/Cruise linesConsumer Services Sleepwell Hotels Ltd. operates as a hotels. The private company is based in Douglas, UK. | Hotels/Resorts/Cruise lines | Director/Board Member Director/Board Member |
Statistieken
Internationaal
| Verenigd Koninkrijk | 22 |
| Frankrijk | 9 |
| Verenigde Staten | 7 |
| Denemarken | 5 |
| Nederland | 3 |
Sectoraal
| Health Technology | 26 |
| Finance | 12 |
| Consumer Services | 7 |
| Commercial Services | 4 |
| Non-Energy Minerals | 3 |
Operationeel
| Director/Board Member | 304 |
| Corporate Officer/Principal | 77 |
| Chairman | 72 |
| Chief Executive Officer | 51 |
| Independent Dir/Board Member | 49 |
Sterkste connecties
| Insiders | |
|---|---|
| Peter James Arthur Benson | 58 |
| Jim Mellon | 51 |
| Denham Eke | 44 |
| Alain Munoz | 38 |
| Gregory Bailey | 36 |
| Christian Herskind Jørgensen | 35 |
| Rémi Droller | 29 |
| Declan Doogan | 28 |
| David Solomon | 22 |
| Franck Noiret | 20 |
| Hervé de Kergrohen | 19 |
| Florian Reinaud | 15 |
| David Roblin | 15 |
| Bruno Chalom Sayada | 15 |
| Jesper Zeuthen | 13 |
- Beurs
- Insiders
- Jean-Christophe Renondin
- Bedrijfsconnecties
